Recommended Resources

  • Cardiovascular Surgery Trials Network (CTSN) – The goal of the CTSN is to foster a culture of rigorous scientific comparisons and to promote the evaluation of newer surgical techniques, devices, and innovative pharmaceutical and bioengineered products directed at improving cardiovascular disease outcomes in adult populations. With support from the National Heart, Lung, and Blood Institute (NHLBI), the National Institute of Neurological Disorders and Stroke (NINDS) at the National Institutes of Health (NIH), and the Canadian Institutes of Health Research (CIHR), the CTSN provides the infrastructure to develop, coordinate, and conduct multiple collaborative proof-of-concept studies and interventional protocols to improve cardiovascular disease outcomes. The Dept. of Health Evidence and Policy at Mt. Sinai School of Medicine serves as the Data Coordinating Center for the CTSN.

  • Center for Medicare and Medicaid Innovations – The mission is to foster health care transformation by finding new ways to pay for and deliver care that improve care and health while lowering costs.

  • NIH National Institute on Minority Health and Health Disparities – The mission is to lead scientific research to improve minority health and eliminate health disparities.

  • The Patient-Centered Outcomes Research Institute (PCORI) – PCORI was established with resources provided through the Patient Protection and Affordable Care Act (ACA), and is authorized by Congress to conduct research to provide information about the best available evidence to help patients and their health care providers make more informed decisions. PCORI’s research is intended to give patients a better understanding of the prevention, treatment and care options available, and the science that supports those options.

  • NIH National Center for Advancing Translational Sciences (NCATS) – The mission is to catalyze the generation of innovative methods and technologies that enhance the development, testing, and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions.

  • C-Trip: Targeted Gene Therapy for the Treatment of Heart Failure – The overall objective of the entire two-staged C-TRIP is to accelerate translation of promising new therapeutic interventions derived from fundamental research discoveries for the treatment and prevention of heart failure or arrhythmias through the planning and execution of well-designed clinical trials to demonstrate safety and efficacy.